Intravascular macrophages in cardiac allograft biopsies for diagnosis of early and late antibody-mediated rejection

Journal of Heart and Lung Transplantation

Volumn 32, Issue 4, 2013, Pages 404-409

  Fedrigo, Marny ^a   Feltrin, Giuseppe ^a   Poli, Francesca ^b   Chiara Frigo, Anna ^a   Benazzi, Elena ^b   Gambino, Antonio ^a   Tona, Francesco ^a   Caforio, Alida L P ^a   Castellani, Chiara ^a   Toscano, Giuseppe ^a   Gerosa, Gino ^a   Thiene, Gaetano ^a   Angelini, Annalisa ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b IRCCS   (Italy)

Author keywords

anti HLA antibodies; antibody mediated rejection; C4d; heart transplantation; immunohistochemistry; intravascular macrophages

Indexed keywords

CD68 ANTIGEN; COMPLEMENT COMPONENT C4D; HLA ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOSUPPRESSIVE AGENT;

ADULT; ANTIBODY MEDIATED REJECTION; ARTICLE; CONTROLLED STUDY; DELAYED DIAGNOSIS; DISEASE SEVERITY; EARLY DIAGNOSIS; FOLLOW UP; GRAFT REJECTION; HEART DISEASE; HEART GRAFT; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; HUMORAL IMMUNITY; IMMUNOSUPPRESSIVE TREATMENT; INTRAVASCULAR MACROPHAGE; MACROPHAGE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIBODIES; BIOPSY; BLOOD VESSELS; GRAFT REJECTION; HEART TRANSPLANTATION; HUMANS; MACROPHAGES; MIDDLE AGED; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84875148619     PISSN: 10532498     EISSN: 15573117     Source Type: Journal    
DOI: 10.1016/j.healun.2012.12.017     Document Type: Article

References (22)

1. E.H. Hammond, R.L. Yowell, and S. Nunoda Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications J Heart Transplant 8 1989 430 443
2. M.E. Hammond, J. Stehlik, and G. Snow Utility of histologic parameters in screening for antibody-mediated rejection of the cardiac allograft: a study of 3,170 biopsies J Heart Lung Transplant 24 2005 2015 2021
3. E.R. Rodriguez, D.V. Skojec, and C.D. Tan Antibody-mediated rejection in human cardiac allografts: evaluation of immunoglobulins and complement activation products C4d and C3d as markers Am J Transplant 5 2005 2778 2785
4. S. Stewart, G.L. Winters, and M.C. Fishbein Revision of the 1990 working formulation for the standardization of nomenclature in the diagnosis of heart rejection J Heart Lung Transplant 24 2005 1710 1720
5. G.W. Wu, J.A. Kobashigawa, and M.C. Fishbein Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes J Heart Lung Transplant 28 2009 417 422
6. E.L. Moseley, C. Atkinson, and L.D. Sharples Deposition of C4d and C3d in cardiac transplants: a factor in the development of coronary artery vasculopathy J Heart Lung Transplant 29 2010 417 423
7. A.G. Kfoury, G.L. Snow, and D. Budge A longitudinal study of the course of asymptomatic antibody-mediated rejection in heart transplantation J Heart Lung Transplant 31 2012 46 51
8. G.J. Berry, A. Angelini, and M.M. Burke The ISHLT working formulation for pathologic diagnosis of antibody-mediated rejection in heart transplantation: evolution and current status (2005-2011) J Heart Lung Transplant 30 2011 601 611
9. M.A. Lones, L.S. Czer, and A. Trento Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients J Heart Lung Transplant 14 1995 151 162
10. B. Sis, and P.F. Halloran Endothelial transcripts uncover a previously unknown phenotype: C4d-negative antibody-mediated rejection Curr Opin Organ Transplant 15 2010 42 48
11. A. Loupy, A. Cazes, and R. Guillemain Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy Am J Transplant 11 2011 1478 1487
12. J.D. Smith, N.R. Banner, and I.M. Hamour De novo donor HLA-specific antibodies after heart transplantation are an independent predictor of poor patient survival Am J Transplant 11 2011 312 319
13. J.J. Deeks, and D.G. Altman Diagnostic tests 4: likelihood ratios BMJ 329 2004 168 169
14. J. Kobashigawa, M.G. Crespo-Leiro, and S.M. Ensminger Report from a consensus conference on antibody-mediated rejection in heart transplantation J Heart Lung Transplant 30 2011 252 269
15. P.J. Michaels, M.L. Espejo, and J. Kobashigawa Humoral rejection in cardiac transplantation: risk factors, hemodynamic consequences and relationship to transplant coronary artery disease J Heart Lung Transplant 22 2003 58 69
16. K. Almuti, J. Haythe, and E. Dwyer The changing pattern of humoral rejection in cardiac transplant recipients Transplantation 84 2007 498 503
17. A.M. Hodges, H. Lyster, and A. McDermott Late antibody-mediated rejection after heart transplantation following the development of de novo donor-specific human leukocyte antigen antibody Transplantation 93 2012 650 656
18. S.K. Takemoto, A. Zeevi, and S. Feng National conference to assess antibody-mediated rejection in solid organ transplantation Am J Transplant 4 2004 1033 1041
19. M. Fedrigo, A. Gambino, and F. Tona Can C4d immunostaining on endomyocardial biopsies be considered a prognostic biomarker in heart transplant recipients? Transplantation 90 2010 791 798
20. M. Fedrigo, A. Gambino, and E. Benazzi Role of morphologic parameters on endomyocardial biopsy to detect sub-clinical antibody-mediated rejection in heart transplantation J Heart Lung Transplant 30 2011 1381 1388
21. B. Sis, G.S. Jhangri, and S. Bunnag Endothelial gene expression in kidney transplants with alloantibody indicates antibody-mediated damage despite lack of C4d staining Am J Transplant 9 2009 2312 2323
22. M. Mengel, B. Sis, and D. Kim The molecular phenotype of heart transplant biopsies: relationship to histopathological and clinical variables Am J Transplant 10 2010 2105 2115